SIRT6 and periodontitis: A Sirt6 activator with anti-inflammatory and anti-osteoclastogenesis properties acts by similar therapeutic mechanisms to host modulators such as monoclonal antibodies, against IL-6 receptor, specialized pro-resolving mediators (SPMs), and complement inhibitors that were recently reported to have periodontitis efficacy [29].